Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: An in vivo cardiovascular magnetic resonance study

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 1, 2010, Pages 120-127

  Larose, Eric ^a,b   Proulx, Guy ^a,b   Voisine, Pierre ^a,b   Rodés Cabau, Josep ^a,b   De Larochellière, Robert ^a,b   Rossignol, Guy ^a,b   Bertrand, Olivier F ^a,b   Tremblay, Jacques P ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Autologous myoblast; Cardiac surgery; Heart failure; Magnetic resonance imaging; Myocardial infarction; Percutaneous intervention; Stem cell therapy

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE PERFUSION; HEART SURGERY; HEART TRANSPLANTATION; IN VIVO STUDY; INTERMETHOD COMPARISON; MYOBLAST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; THORACOTOMY;

ANIMALS; ARRHYTHMIAS, CARDIAC; CELLS, CULTURED; CHRONIC DISEASE; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; FIBROSIS; HEART CATHETERIZATION; INJECTIONS; MAGNETIC RESONANCE IMAGING; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIUM; RECOVERY OF FUNCTION; STROKE VOLUME; SWINE; SWINE, MINIATURE; THORACOTOMY; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 74249109336     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22204     Document Type: Article

References (31)

1. Public HealthAgency of Canada. NCD Surveillance Infobase for Canada. Available at: http:cvdinfobase.ca/surveillance. Accessed October 2005.
2. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-933.
3. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-2523.
4. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, Marolleau JP, Desnos M, Bruneval P. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003;361:491-492.
5. Reinecke H, MacDonald GH, Hauschka SD, Murry CE. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000;149:731-740.
6. Atkins BZ, Hueman MT, Meuchel JM, Cottman MJ, Hutcheson KA, Taylor DA. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant 1999;18:1173-1180.
7. Taylor DA., Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Curr Control Trials Cardiovasc Med 2001;2:208-210.
8. Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagege AA. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-1200.
9. Menasche P. Skeletal myoblast for cell therapy. Coron Artery Dis 2005;16:105-110.
10. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Four-year follow-up. Circulation 2005;112:1748-1755.
11. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Cardiol 2003;42:2063-2069.
12. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Myoblast transplantation for heart failure. Lancet 2001;357:279-280.
13. Skuk D, Tremblay JP. Myoblast transplantation: The current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil 2003;24:285-300.
14. Larose E, Cote J, Rodes-Cabau J, Noel B, Barbeau G, Bordeleau E, Miro S, Brochu B, Delarochelliere R, Bertrand OF. Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction. Int J Cardiovasc Imaging 2009;25:519-527.
15. Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, Kwong RY. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007;49:855-862.
16. Brody S, Comfort J, Matthews J. Further investigations on surface area with special reference to its significance in energy metabolism. Mo Agr Exp Sta Bull 1928;115.
17. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, Marincek B, Luscher TF, von Schulthess GK. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: A comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-2235.
18. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
19. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-1108.
20. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-39.
21. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-542.
22. Koh GY, Klug MG, Soonpaa MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 1993;92:1548-1554.
23. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, Zawadzka A, Wetzel K, Sawyer DB, Colucci WS, Apstein CS, Liao R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001;103:1920-1927.
24. Simniak T, Kalawski R, Fiszer D, Klimowicz A, Kurpisz M. Myoblast transplantation in the treatment of post-infarction heart failure. Kardiol Pol 2002;57:354-358.
25. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-1083.
26. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzezniczak J, Rozwadowska N, Kurpisz M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 2004;148:531-537.
27. Herreros J, Prosper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, Sanchez PL, Canizo C, Rabago G, Marti-Climent JM, Hernandez M, Lopez-Holgado N, Gonzalez-Santos JM, Martin-Luengo C, Alegria E. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with nonacute myocardial infarction. Eur Heart J 2003;24:2012-2020.
28. Menasche P. Skeletal muscle satellite cell transplantation. Cardiovasc Res 2003;58:351-357.
29. Dib N, Diethrich EB, Campbell A, Goodwin N, Robinson B, Gilbert J, Hobohm DW, Taylor DA. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther 2002;9:313-319.
30. Strom TB, Field LJ, Ruediger M, Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine. Transplant Proc 2001;33:3044-3049.
31. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-888.